Reformulated Cepharanthine (Sairiyo Therapeutics Inc)

N/A

Report date: 2025/06/10 17:55:06

Base Information

Drug NameReformulated Cepharanthine (Sairiyo Therapeutics Inc)
Drug Alias NamePD-001PD001
ClassificationSmall molecules > Heterocyclic drugsNatural product/Extract > Plants extract
Mechanisms of ActionAngiogenesis inhibitorsApoptosis inducersG-protein coupled estrogen receptor 1 agonists +[6] 
TargetsG-protein coupled estrogen receptor 1Mu opioid receptorNuclear factor NF-kappa-B complex
Therapy Area/IndicationsNeoplasmsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSairiyo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSairiyo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasmsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A